Company BioLife Solutions, Inc.

Equities

BLFS

US09062W2044

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
16.86 USD -1.92% Intraday chart for BioLife Solutions, Inc. +6.31% +3.75%

Business Summary

BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Its expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage and distribution. Its biopreservation media products, HypoThermosol FRS and CryoStor Freeze Media, are formulated to mitigate preservation-induced, delayed-onset cell damage and death which result when cells and tissues are subjected to reduced temperatures. Its bioproduction tools portfolio includes human platelet lysates for cell expansion. It is a provider of biological and pharmaceutical storage and cold chain logistics. Its monitoring systems allow customers real time tracking of the storage temperatures of their materials throughout the logistics process. It operates about five storage facilities in the United States and one facility in the Netherlands.

Sales per Business

USD in Million2022Weight2023Weight Delta
Cell Processing - Product
45.9 %
69 42.4 % 66 45.9 % -4.00%
Freezer and Thaw - Product
35.3 %
67 41.2 % 51 35.3 % -24.08%
Biostorage Services - Service
11.5 %
15 9.4 % 17 11.5 % +8.49%
Biostorage Services - Rental
5.6 %
10 6.5 % 8 5.6 % -23.21%
Biostorage Services - Product
0.9 %
1 0.5 % 1 0.9 % +60.82%
Freezer and Thaw - Service
0.7 %
0 0.0 % 1 0.7 % +1,283.78%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
80.0 %
116 72.0 % 115 80.0 % -1.59%
Europe, Middle East, Africa (EMEA)
16.0 %
11 7.0 % 23 16.0 % +102.45%
Other
4.0 %
6 4.0 % 6 4.0 % -11.43%

Managers

Managers TitleAgeSince
Founder 52 97-12-31
Chief Executive Officer 63 16-03-03
Director of Finance/CFO 39 14-12-31
Chief Operating Officer 64 16-04-12
Corporate Officer/Principal - 21-04-30
Corporate Officer/Principal - 20-06-30
Human Resources Officer 48 20-01-31
Corporate Officer/Principal 51 23-09-30
Sales & Marketing 55 14-06-30

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 63 16-03-03
Director/Board Member 62 13-11-17
Director/Board Member 62 22-08-31
Director/Board Member 52 21-09-30
Director/Board Member 50 21-04-05
Director/Board Member 54 21-04-05

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 45,300,000 43,699,889 ( 96.47 %) 0 96.47 %

Shareholders

NameEquities%Valuation
Casdin Capital LLC
19.22 %
8,707,165 19.22 % 162 M $
BlackRock Advisors LLC
11.54 %
5,225,925 11.54 % 97 M $
Vanguard Fiduciary Trust Co.
5.677 %
2,571,608 5.677 % 48 M $
Goldman Sachs Asset Management LP
5.302 %
2,401,899 5.302 % 45 M $
Millennium Management LLC
5.105 %
2,312,650 5.105 % 43 M $
William Blair Investment Management LLC
3.781 %
1,712,927 3.781 % 32 M $
Fred Alger Management LLC (13f Subfiler)
3.587 %
1,625,036 3.587 % 30 M $
Columbia Wanger Asset Management LLC
3.089 %
1,399,272 3.089 % 26 M $
Granahan Investment Management, LLC
2.854 %
1,292,675 2.854 % 24 M $
1,249,671 2.759 % 23 M $

Company contact information

BioLife Solutions, Inc.

3303 Monte Villa Parkway Suite 310

98021, Bothell

+425 402 1400

http://www.biolifesolutions.com
address BioLife Solutions, Inc.(BLFS)
  1. Stock Market
  2. Equities
  3. BLFS Stock
  4. Company BioLife Solutions, Inc.